Oral Bioavailability of Pterostilbene Cocrystal Compared to Its Free Form (BIOPTERO)

Exclusion Criteria

• •Take supplements or multivitamin supplements or phytotherapeutic products (especially infusions) that interfere with the treatment under study up to 30 days before the start of the study.
• •Be lacto-vegetarian, lacto-ovo-vegetarian, or vegan.
• •Present intolerances and/or food allergies related to pterostilbene.
• •Be a smoker.
• •Having received antibiotic treatment up to 30 days before the start of the study.
• •Present values of body mass index ≤ 18kg/m\^2 or ≥ 35 kg/m\^2.
• •Present some chronic disease with clinical manifestations: coronary heart disease, cardiovascular disease, diabetes, celiac disease, Crohn's disease, chronic kidney disease, cancer, autoimmune diseases (such as fibromyalgia), respiratory and/or gastrointestinal diseases that may compromise the absorption of the compound.
• •Clinical history of anemia.
• •Being pregnant or intending to became pregnant.
• •Be in breastfeeding period.
• •Being unable to follow the study guidelines.
• •Participate in or have participated in a clinical trial or nutritional intervention study in the last 30 days before inclusion in the study.